1. Adkins J.C., McTavish D. Salmeterol: a review of its pharmacological properties and clinical efficacy in management of children with asthma// Drugs.- 1997.- Vol.54.- P. 331- 354.
2. Bateman E.D., Britton М ., Carrillo J., et al. Salmelerol/fluticasone combination inhaler: a new, effective and well tolerated treatment for asthma//Clin. Drug Invest.- 1998.- Vol.16.- P. 193-201.
3. Broaden R.N., Faulds D. Salmeterol xinafoate: a review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease//Drugs.- 1991.- Vol.42P. 895-912.
4. Chapman K.R., Ringdal N„ Backer V., et al. Salmeterol and fluticasone propionate (50/250mcg) administered via combination Discus inhaler: as effective as when given via separate Diskus inhalers//Can. Respir. J.- 1999.- Vol.6, N .I.- P.45-51.
5. Chung K.F. The complementary role of glucocorticosteroids and long-acting (Vadrenergic agonists// Allergy.- 1998.- Vol. 53, Suppl.42.- P.7-13.
6. Coutts J.A.P., Gibson N.A., Paton J.Y. Measuring compliance with inhaled medication in asthma//Arch. Dis. Child.- 1992.- Vol.67.- P.332-333.
7. Dahl R. Salmeterol and fluticasone propionate in the treatment of asthma symptoms//Eur. Resp. Rev.- 1997.- №.7.- Vol.P. 338-343.
8. Davies B., Brooks G., Devoy M. The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine control stiudies//Respir. Med.- 1998.- Vol.92.- P.256- 263.
9. Edwards T., Gross G., Mitchell D., et al. The salmeterol xinafo-ate/fluticasone propionate dry powder combination product via Diskus inhaler improves asthma control compared to salmeterol xinafoate or fluticasone propionate alone [abstract]//Am. J. Respir. Crit. Care Med.- 1998.- Vo.157, (Pt2) Suppl., P.A414.
10. Eickelberg O., Roth M., Lorx R., et al. Ligand-independent actvation of the glucocorticoid receptor by p2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells//J. Biol. Chem.- 1999.- Vol.274, N.2.- P. 1005- 1010.
11. Green S.A., Spasoff A.P., Coleman R.A., et al. Sustained activation of a G protein-coupled receptor via 'anchored' agonist binding. Molecular localization of the salmeterol exosite within the p2-adrenergic receptor//J. Biol. Chem. 1996.- P. 2429-2435.
12. Greening A.P., Ind P.W., Northfield M., Allen&Hanburys Limited UK Study Group, et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid//Lancet.- 1994.- Vol.344, №.8917.- P. 219-224.
13. Holliday S.M ., Faulds D., Sorkin L.M. Inhaled fluticasone propionate: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma//Drugs.- 1994.- Vol.47.- P.318- 331.
14. Ind P.W., Dal Negro R., Colman N., et al. Inhaled fluticasone propionate and salmeterol in moderate adult asthma II: exacerbations [abstract]// Am. J. Respir. Crit. Care Med.- 1998.- Vol.157 (Pt2), Suppl.- P. A415.
15. Ind P.W., Dal Negro R., Colman N., et al. Inhaled fluticasone propionate and salmeterol in moderate adult asthma I: lung function and symptoms [abstract]// Am. J. Respir. Crit. Care Med.- 1998.- Vol.157, (Pt2), Suppl.- P.A416.
16. Jack D. The use of inhaled p2 adrenergic hronchodilators and anti-inflammatory steroids in asthma// J. Pharmaceut. Med.- 1996.- Vol.6, №.1- 2.- P.5- 16.
17. Jarvis B., Faulds D. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages <500 meg/day in adults and adolescents with mild to moderate asthma// Drugs.- 1999.- Vol.57.- P.769- 803.
18. Johnson M. Development of fluticasone propionate and comparison with other inhaled corticosteroids// J. Allergy Clin. Immunol.- 1998.- Vol.101, (Part 2) Suppl.- P. 434-439.
19. Kalberg J.C., Yancey S., Emmett A.H., et al. A comparison of salmeterol versus zafirlucast in patients using inhaled corticosteroids [abstract]// J. Allergy Clin. Immunol.- 1999.- Vol.103.- P.S229.
20. Lumry W., Windom H., Mendelson L., et al. The salmeterol/fluticasone propionate (50/250mcg) dry powder combination Diskus has a faster onset of effect compared with salmeterol or fluticasone propionate in patients with asthma// J. Allergy Clin. Immunol.- 1999.- Vol. 103, Pt2.- P.132.
21. National Institutes of Health. Global initiative for asthma. Global strategy for asthma management and prevention N H LB/ WHO workshop report [online]. Global Initiative for Asthma and National Heart, Lung and Blood Institute; 1995 Jan. Available from: URL: http://www.ginasthma.com/workshop/default.html [Accessed 1999 May 5].
22. Pieters W.R., Steinmetz K.O., Aubier М., et al. Effectiveness of a new salmeterol/fluticasone propionate (50/500 meg) combination inhaler in patients with reversible airways obstruction [abstract]// Eur. Respir. J.- 1998.- Vol. 12, Suppl. 28.- P. 35s.
23. Reese P.R., Mahajan P., Woodring A. Salmeterol/fluticasone pro-pionate combination product improves quality of life in asthma patients [abstract]// Eur. Respir. J.- 1998.- Vol.12, Suppl. 28.- P.35s.
24. Reese P.R., Mather D.B., Mahajan P., et al. Combination of salmeterol/ flutica-sone propionate via Diskus improves quality of life in asthma patients [abstract]//J. Allergy Clin. Immunol.- 1999.- Vol.103, Pt2.- P.69.
25. Seretide. Monograph. Glaxo Wellcome UK. 1998.
26. Sly R.M. New guidelines for diagnosis and management of asthma/ / Ann. Allergy Asthma Immunol.- 1997.- Vol.78.- P.427-437.
27. Verberne A.A.P.H., Frost C., Duiverman E.J., et al. Addition of salmeterol versus doubling the dose of beclamethasone in children with asthma// Am. J. Respir. Crit. Care Med.- 1998 Vol.158.- P.213- 219.5p
28. Woolcock A., Lundback B., Ringdal N., et al. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids// Am. J. Respir. Crit. Care Med.- 1996.- Vol.153, N.5.- P.1481 - 1488.
29. Zimmerman B., Gold М., Wherrett D., et al. Adrenal suppression in two patients with asthma treated with low doses of the inhaled steroid fluticasone propionate// J. Allergy Clin. Immunol.- 1998.- Vol.101.- P.425- 426.
Послать статью по эл. почте 